BRKRP vs PATH · rev $3.37B vs P/E 19, rev $1.61B
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) common stock listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BRKRP revenue for 2024-12-31 was $3.37B. Net income was $113.8M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. BRKRP currently screens at market cap $0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BRKRP currently screens at market cap $0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BRKRP and PATH stock pages for the full models.
Not investment advice.